{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:11:46Z","timestamp":1780049506875,"version":"3.53.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,19]]},"DOI":"10.7759\/cureus.12175","type":"journal-article","created":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T21:21:02Z","timestamp":1608412862000},"source":"Crossref","is-referenced-by-count":4,"title":["A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sj\u00f6gren Syndrome"],"prefix":"10.7759","author":[{"given":"Takanori","family":"Ohta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadafumi","family":"Tamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-1979-1","article-title":"Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version","volume":"103","author":"Masaki Y","year":"2016","unstructured":"Masaki Y, Kawabata H, Takai K, et al.. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016, 103:686-692. 10.1007\/s12185-016-1979-1","journal-title":"Int J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02780-1","article-title":"2019 updated diagnostic criteria and disease severity classification for TAFRO syndrome","volume":"111","author":"Masaki Y","year":"2020","unstructured":"Masaki Y, Kawabata H, Takai K, et al.. 2019 updated diagnostic criteria and disease severity classification for TAFRO syndrome. Int J Hematol. 2020, 111:155-158. 10.1007\/s12185-019-02780-1","journal-title":"Int J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009220","article-title":"Sj\u00f6gren\u2019s syndrome manifesting as clinicopathological features of TAFRO syndrome. A case report","volume":"96","author":"Fujimoto S","year":"2017","unstructured":"Fujimoto S, Kawabata H, Kurose N, et al.. Sj\u00f6gren\u2019s syndrome manifesting as clinicopathological features of TAFRO syndrome. A case report. Medicine (Baltimore). 2017, 96:e9220. 10.1097\/MD.0000000000009220","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.2502","article-title":"Multicentric Castleman disease with TAFRO syndrome and Sj\u00f6gren's","volume":"7","author":"Li ZY","year":"2019","unstructured":"Li ZY, Kim S, Huang S, Mian R. Multicentric Castleman disease with TAFRO syndrome and Sj\u00f6gren's. Clin Case Rep. 2019, 7:2388-2392. 10.1002\/ccr3.2502","journal-title":"Clin Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00149","article-title":"TAFRO syndrome in Caucasians: a case report and review of the literature","volume":"4","author":"Louis C","year":"2017","unstructured":"Louis C, Vijgen S, Samii K, et al.. TAFRO syndrome in Caucasians: a case report and review of the literature. Front Med. 2017, 4:149. 10.3389\/fmed.2017.00149","journal-title":"Front Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0116-17","article-title":"Remission of refractory ascites and discontinuation of hemodialysis after additional rituximab to long-term glucocorticoid therapy in a patient with TAFRO syndrome","volume":"57","author":"Tsurumi H","year":"2018","unstructured":"Tsurumi H, Fujigaki Y, Yamamoto T, et al.. Remission of refractory ascites and discontinuation of hemodialysis after additional rituximab to long-term glucocorticoid therapy in a patient with TAFRO syndrome. Intern Med. 2018, 57:1433-1438. 10.2169\/internalmedicine.0116-17","journal-title":"Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8522-16","article-title":"Successful treatment of TAFRO syndrome with tocilizumab, prednisone, and cyclophosphamide","volume":"56","author":"Kikuchi T","year":"2017","unstructured":"Kikuchi T, Shimizu T, Toyama T, Abe R, Okamoto S. Successful treatment of TAFRO syndrome with tocilizumab, prednisone, and cyclophosphamide. Intern Med. 2017, 56:2205-2211. 10.2169\/internalmedicine.8522-16","journal-title":"Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24242","article-title":"Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease","volume":"91","author":"Iwaki N","year":"2016","unstructured":"Iwaki N, Fajgenbaum DC, Nabel CS, et al.. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol. 2016, 91:220-226. 10.1002\/ajh.24242","journal-title":"Am J Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum DC","year":"2017","unstructured":"Fajgenbaum DC, Uldrick TS, Bagg A, et al.. International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease. Blood. 2017, 129:1646-1657. 10.1182\/blood-2016-10-746933","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)00006-5","article-title":"Idiopathic multicentric Castleman's disease: a systematic literature review","volume":"3","author":"Liu AY","year":"2016","unstructured":"Liu AY, Nabel CS, Finkelman BS, et al.. Idiopathic multicentric Castleman's disease: a systematic literature review. Lancet Haematol. 2016, 3:163-175. 10.1016\/S2352-3026(16)00006-5","journal-title":"Lancet Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0366-6999.2010.22.015","article-title":"Clinical and prognostic characteristics of 573 cases of primary Sj\u00f6gren's syndrome [Article in Chinese]","volume":"123","author":"Lin DF","year":"2010","unstructured":"Lin DF, Yan SM, Zhao Y, et al.. Clinical and prognostic characteristics of 573 cases of primary Sj\u00f6gren's syndrome [Article in Chinese]. Chin Med J. 2010, 123:3252-3267. 10.3760\/cma.j.issn.0366-6999.2010.22.015","journal-title":"Chin Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006271","article-title":"A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids. The first case report in Latin America","volume":"96","author":"Jos\u00e9 FF","year":"2017","unstructured":"Jos\u00e9 FF, Kerbauy LN, Perini GF, et al.. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids. The first case report in Latin America. Medicine (Baltimore). 2017, 96:e6271. 10.1097\/MD.0000000000006271","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001597982","article-title":"Autoimmune myelofibrosis: report of three cases and review of the literature","volume":"45","author":"Rizzi R","year":"2004","unstructured":"Rizzi R, Pastore D, Liso A, et al..  Autoimmune myelofibrosis: report of three cases and review of the literature. Leuk Lymphoma. 2004, 45:561-566. 10.1080\/10428190310001597982","journal-title":"Leuk Lymphoma"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005565","article-title":"Clinical characteristics of immune thrombocytopenia associated with autoimmune disease. A retrospective study","volume":"95","author":"Liu Y","year":"2016","unstructured":"Liu Y, Chen S, Sun Y, et al.. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease. A retrospective study. Medicine (Baltimore). 2016, 95:e5565. 10.1097\/MD.0000000000005565","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/srep42316","article-title":"Elevated serum interferon \u03b3-induced protein 10 kDa is associated with TAFRO syndrome","volume":"7","author":"Iwaki N","year":"2017","unstructured":"Iwaki N, Gion Y, Kondo E, et al.. Elevated serum interferon \u03b3-induced protein 10 kDa is associated with TAFRO syndrome. Sci Rep. 2017, 7:42316. 10.1038\/srep42316","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2014.917764","article-title":"Thrombotic microangiopathy complicating newly diagnosed Sj\u00f6gren's syndrome in a dialysis patient","volume":"36","author":"Cheng MH","year":"2014","unstructured":"Cheng MH, Lin JH, Yen TH, et al.. Thrombotic microangiopathy complicating newly diagnosed Sj\u00f6gren's syndrome in a dialysis patient. Ren Fail. 2014, 36:1162-1165. 10.3109\/0886022X.2014.917764","journal-title":"Ren Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1160\/TH08-12-0825","article-title":"Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases","volume":"102","author":"Matsuyama T","year":"2009","unstructured":"Matsuyama T, Kuwana M, Matsumoto M, Isonishi A, Inokuma S, Fujimura Y. Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases. Thromb Haemost. 2009, 102:371-378. 10.1160\/TH08-12-0825","journal-title":"Thromb Haemost"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000220","article-title":"Tocilizumab-associated multifocal cerebral thrombotic microangiopathy","volume":"6","author":"Jewell P","year":"2016","unstructured":"Jewell P, Ansorge O, Kuker W, Irani SR, Zamboni G. Tocilizumab-associated multifocal cerebral thrombotic microangiopathy. Neurol Clin Pract. 2016, 6:e24-e26. 10.1212\/CPJ.0000000000000220","journal-title":"Neurol Clin Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2015.07.005","article-title":"An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document [Article in Spanish]","volume":"35","author":"Campistol JM","year":"2015","unstructured":"Campistol JM, Arias M, Ariceta G, et al.. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document [Article in Spanish]. Nefrologia. 2015, 35:421-447. 10.1016\/j.nefro.2015.07.005","journal-title":"Nefrologia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102364","article-title":"Sj\u00f6gren's syndrome: old and new therapeutic targets","volume":"110","author":"Mavragani CP","year":"2020","unstructured":"Mavragani CP, Moutsopoulos HM. Sj\u00f6gren's syndrome: old and new therapeutic targets.  J Autoimmun. 2020, 110:102364. 10.1016\/j.jaut.2019.102364","journal-title":"J Autoimmun"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/33772-a-case-of-repeated-tafro-syndrome-like-symptoms-and-retroperitoneal-hemorrhage-in-a-patient-with-sjgren-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:25:03Z","timestamp":1707506703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/33772-a-case-of-repeated-tafro-syndrome-like-symptoms-and-retroperitoneal-hemorrhage-in-a-patient-with-sjgren-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,19]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.12175","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,19]]}}}